Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that ...

Learn more about whether Glaukos Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Business may be picking up for locally-based drugmakers just a year after the local sector was showing declines.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

Orange County is home to some of the hottest medical device and biotechnology companies, producing a range of drugs and ...

Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues, which decreases over time.

MINT, a stent-free platform, helps treat adult patients undergoing glaucoma angle surgery. The system utilizes a unique ...

Christine Funke, MD, glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, discusses how the ...

While glaucoma prevalence is growing, glaucoma specialists are in short supply, and accessibility to specialized centers is ...